Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
The Lancet. Neurology
|
May 15, 2012
First-line treatment for CIDP: a new piece of the puzzle
Ivo N van Schaik
Journal of the Peripheral Nervous System : JPNS
|
February 5, 2009
What's new in chronic inflammatory demyelinating polyradiculoneuropathy in 2007-2008?
Ivo N van Schaik
Expert Opinion on Biological Therapy
|
February 9, 2011
Immunotherapy of multifocal motor neuropathy
Filip Eftimov, Ivo N Van Schaik
The Lancet. Neurology
|
April 17, 2018
Intravenous versus subcutaneous immunoglobulin - Authors' reply
Ivo N van Schaik, Orell Mielke,
Journal of the Peripheral Nervous System : JPNS
|
June 1, 2016
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop
Max E Adrichem, Filip Eftimov, Ivo N van Schaik
BMC Neurology
|
April 9, 2014
Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
Filip Eftimov, Marinus H Liesdek, Camillus Verhamme, et al.
The Lancet. Neurology
|
July 10, 2003
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review
Ivo N van Schaik, John B Winer, Rob de Haan, et al.
The Lancet. Neurology
|
May 24, 2005
Confusing Cochrane reviews on treatment in multiple sclerosis
Brigit A de Jong, Marc Engelen, Ivo N van Schaik, et al.
Current Pain and Headache Reports
|
September 3, 2013
Fabry disease: a rare cause of neuropathic pain
Marieke Biegstraaten, Gabor E Linthorst, Ivo N van Schaik, et al.
Journal of Rehabilitation Medicine
|
September 24, 2009
Limited upper limb functioning has impact on restrictions in participation and autonomy of patients with hereditary motor and sensory neuropathy 1a
Annemieke J Videler, Anita Beelen, Ivo N van Schaik, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
The Lancet. Neurology
|
May 15, 2012
First-line treatment for CIDP: a new piece of the puzzle
Ivo N van Schaik
Journal of the Peripheral Nervous System : JPNS
|
February 5, 2009
What's new in chronic inflammatory demyelinating polyradiculoneuropathy in 2007-2008?
Ivo N van Schaik
Expert Opinion on Biological Therapy
|
February 9, 2011
Immunotherapy of multifocal motor neuropathy
Filip Eftimov, Ivo N Van Schaik
The Lancet. Neurology
|
April 17, 2018
Intravenous versus subcutaneous immunoglobulin - Authors' reply
Ivo N van Schaik, Orell Mielke,
Journal of the Peripheral Nervous System : JPNS
|
June 1, 2016
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop
Max E Adrichem, Filip Eftimov, Ivo N van Schaik
BMC Neurology
|
April 9, 2014
Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
Filip Eftimov, Marinus H Liesdek, Camillus Verhamme, et al.
The Lancet. Neurology
|
July 10, 2003
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review
Ivo N van Schaik, John B Winer, Rob de Haan, et al.
The Lancet. Neurology
|
May 24, 2005
Confusing Cochrane reviews on treatment in multiple sclerosis
Brigit A de Jong, Marc Engelen, Ivo N van Schaik, et al.
Current Pain and Headache Reports
|
September 3, 2013
Fabry disease: a rare cause of neuropathic pain
Marieke Biegstraaten, Gabor E Linthorst, Ivo N van Schaik, et al.
Journal of Rehabilitation Medicine
|
September 24, 2009
Limited upper limb functioning has impact on restrictions in participation and autonomy of patients with hereditary motor and sensory neuropathy 1a
Annemieke J Videler, Anita Beelen, Ivo N van Schaik, et al.
Page
of 10